Both are within the 28-day stability window
Just provide your email below and further details will be sent to you
While these are population-level numbers, the principle applies to individuals as well: routine injection visits for non-deficient patients add up in copays, travel time, and appointment scheduling without delivering additional benefit
I am going through the same thing
Common experiences include: Injection site reactions: Redness, minor swelling, tenderness (resolves within hours) Transient fatigue: Mild tiredness during first 1 to 2 weeks, especially with TB-500 Headaches: Occasional mild headaches, typically in early use Vivid dreams: Some users report more memorable or intense dreams Temporary water retention: Minor and resolves with continued use Serious adverse events with healing peptides remain rare in documented use
Important Note on the Evidence Base Important note on the evidence base: The preclinical AOD-9604 literature in obese mouse and Zucker rat models is consistent and reproducible